Indices of platelet activation and the stability of coronary artery disease

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 4, 2007, Pages 761-765

  Linden, M D ^a   Furman, M I ^a   Frelinger III, A L ^a   Fox, M L ^a   Barnard, M R ^a   Li, Y ^a   Przyklenk, K ^a   Michelson, Alan D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Aspirin; Coronary artery disease; Flow cytometry; PFA 100; Platelet activation; Platelets

Indexed keywords

ACETYLSALICYLIC ACID; ADRENALIN; CD40 LIGAND; COLLAGEN; CREATINE KINASE MB; FIBRINOGEN RECEPTOR; PADGEM PROTEIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL AGGREGATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY ARTERY THROMBOSIS; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG RESPONSE; FEMALE; HEART CATHETERIZATION; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; THROMBOCYTE MEMBRANE;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CD40 LIGAND; CORONARY ARTERIOSCLEROSIS; EPINEPHRINE; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUTROPHILS; P-SELECTIN; PLATELET ACTIVATION; PLATELET FUNCTION TESTS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;

EID: 34147120259     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02462.x     Document Type: Article

References (23)

1. Goldschmidt PJ, Lopes N, Crawford LE, Becker RC. Atherothrombosis and coronary artery disease. In: Michelson AD, ed. Platelets. San Diego: Elsevier/Academic Press, 2007; 629-56.
2. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 2002; 8: 1227-34.
3. Fitzgerald DJ, Roy L, Catella F, FitzGerald GA. Platelet activation in unstable coronary disease. N Engl J Med 1986; 315: 983-9.
4. Furman MI, Benoit SE, Barnard MR, Valeri CR, Borbone ML, Becker RC, Hechtman HB, Michelson AD. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31: 352-8.
5. Furman MI, Barnard MR, Krueger LA, Fox ML, Shilale EA, Lessard DM, Marchese P, Frelinger III AL, Goldberg RJ, Michelson AD. Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction. J Am Coll Cardiol 2001; 38: 1002-6.
6. Michelson AD, Barnard MR, Krueger LA, Valeri CR, Furman MI. Circulating monocyte-platelet aggregates are a more sensitive marker of in vivo platelet activation than platelet surface P-selectin: Studies in baboons, human coronary intervention, and human acute myocardial infarction. Circulation 2001; 104: 1533-7.
7. Francis JL. The platelet function analyzer (PFA)-100. In: Michelson AD, ed. Platelets, 2nd edn. San Diego: Elsevier/Academic Press, 2007; 519-34.
8. Ott I, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation 1996; 94: 1239-46.
9. Shattil SJ, Hoxie JA, Cunningham M, Brass LF. Changes in the platelet membrane glycoprotein IIb-IIIa complex during platelet activation. J Biol Chem 1985; 260: 11107-14.
10. McEver RP. P-Selectin/PSGL-1 and other interactions between platelets, leukocytes, and endothelium. In: Michelson AD, ed. Platelets. San Diego: Elsevier/Academic Press, 2007; 231-50.
11. Coulter SA, Cannon CP, Ault KA, Antman EM, Van de Werf F, Adgey AA, Gibson CM, Giugliano RP, Mascelli MA, Scherer J, Barnathan ES, Braunwald E, Kleiman NS. High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: Results from TIMI (thrombolysis in myocardial infarction) 14. Circulation 2000; 101: 2690-5.
12. Andre P, Nannizzi-Alaimo L, Prasad SK, Phillips DR. Platelet-derived CD40 L: The switch-hitting player of cardiovascular disease. Circulation 2002; 106: 896-9.
13. Furman MI, Krueger LA, Linden MD, Barnard MR, Frelinger III AL, Michelson AD. Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization. J Am Coll Cardiol 2004; 43: 2319-25.
14. Linden MD, Frelinger III AL, Barnard MR, Przyklenk K, Furman MI, Michelson AD. Application of flow cytometry to platelet disorders. Semin Thromb Hemost 2004; 30: 501-11.
15. Furman MI, Krueger LA, Linden MD, Fox ML, Ball SP, Barnard MR, Frelinger III AL, Michelson AD. GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention. J Thromb Haemost 2005; 3: 312-20.
16. Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, Lopez-Sendon J, Klein W, Mukherjee D, Eagle KA, Dabbous OH, Goldberg RJ, on behalf of GRACE Investigators. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: Findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2004; 147: 42-8.
17. Frossard M, Fuchs I, Leitner JM, Hseih K, Vlcek M, Losert H, Domanovits H, Schreiber W, Laggner AN, Jilma B. Platelet function predicts myocardial damage in patients with acute myocardial infarction. Circulation 2004; 110: 1392-7.
18. Campo G, Valgimigli M, Gemmati D, Percoco G, Tognazzo S, Cicchitelli G, Catozzi L, Malagutti P, Anselmi M, Vassanelli C, Scapoli G, Ferrari R. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. J Am Coll Cardiol 2006; 48: 2178-85.
19. Lanza GA, Sestito A, Iacovella S, Morlacchi L, Romagnoli E, Schiavoni G, Crea F, Maseri A, Andreotti F. Relation between platelet response to exercise and coronary angiographic findings in patients with effort angina. Circulation 2003; 107: 1378-82.
20. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, Valeri CR. In vivo tracking of platelets: Circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci USA 1996; 93: 11877-82.
21. Cattaneo M. ADP receptor antagonists. In: Michelson AD, ed. Platelets. San Diego: Elsevier/Academic Press, 2007; 1127-44.
22. Mueller T, Haltmayer M, Poelz W, Haidinger D. Monitoring aspirin 100 mg and clopidogrel 75 mg therapy with the PFA-100 device in patients with peripheral arterial disease. Vasc Endovascular Surg 2003; 37: 117-23.
23. Yip HK, Chang LT, Sun CK, Chen MC, Yang CH, Hung WC, Hsieh YK, Fang CY, Hang CL, Wu CJ, Chang HW. Impact of clopidogrel on suppression of circulating levels of soluble CD40 ligand in patients with unstable angina undergoing coronary stenting. Am J Cardiol 2006; 97: 192-4.